Dr. Carson received his BA from Hartford College in Haverford, PA, and received his MD at Columbia University, New York, NY.
- The molecular genetic basis for rheumatoid arthritis; rational development of anti-rheumatic therapy
- Autoimmune disease
- Cancers of the lymphoid tissues
Research Focus and Location
Moores Cancer Center
Sen M, Cheng Y-H, Goldring MB, Lotz MK, Carson DA. WISP3-dependent regulation of type II collagen and aggrecan production in chondrocytes. Arthritis Rheum 50:488-497, 2004.
Lu D, Zhao Y, Tawatao R, Cottam HB, Sen M, Leoni LM, Kipps TJ, Corr M, Carson DA. Activation of the Wnt signaling pathway in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 101:3118-3123, 2004.
Hedvat M, Jain A, Carson DA, Leoni LM, Huang G, Holden S, Lu D, Corr M, Fox W, Agus DB. Inhibition of HER-kinase activation prevents ERK-mediated degradation of PPARγ. Cancer Cell 5:565-574, 2004.
Loughlin J, Dowling B, Chapman K, Marcelline L, Mustafa Z, Southam L, Ferreira A, Ciesielski C, Carson DA, Corr M. Functional variants within the secreted frizzled-related protein 3 gene are associated with hip osteoarthritis in females. Proc Natl Acad Sci USA 101:9757-9762, 2004.
Wu CCN, Lee J, Raz E, Corr M, Carson DA. Necessity of oligonucleotide aggregation for Toll-like receptor 9 activation. J Biol Chem 279:33071-33078, 2004.
Additional Carson Publications via PubMed